Episodes

  • What’s New and What’s Next in CLL

    What’s New and What’s Next in CLL
    Feb 17 2026

    Brad Kahl, MD, Siteman Cancer Center, St. Louis MO

    Recorded on January 27, 2026


    Brad Kahl, MD
    Professor of Medicine
    Division of Oncology, Department of Medicine
    Washington University School of Medicine
    Director, Lymphoma Program
    Siteman Cancer Center
    St. Louis, MO
    In this episode, join Dr. Brad Kahl, Director of the Lymphoma Program at the Siteman Cancer Center in St. Louis, Missouri, as he delivers a concise and practical overview of chronic lymphocytic leukemia (CLL), from initial disease presentation to key diagnostic considerations. Dr. Kahl discusses the prognostic value of cytogenetic testing and its impact on treatment selection and reviews currently approved therapeutic options alongside notable updates from the latest American Society of Hematology (ASH) meeting. He also examines emerging agents and ongoing clinical trials that are shaping the future CLL treatment landscape. The conversation further explores strategies for managing side effects, addressing complications, and supporting patients and caregivers. Tune in for this timely and informative discussion!

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Resources for Patients
    Show More Show Less
    39 mins
  • Guiding Fertility Care for Adolescents and Young Adults

    Guiding Fertility Care for Adolescents and Young Adults
    Feb 4 2026

    Pam Simon, MSN, CPNP, CPON, Stanford Adolescent and Young Adult Cancer Program (SAYAC), Palo Alto, CA and H. Irene Su, MD MSCE, University of California San Diego, San Diego, CA

    Recorded on January 20, 2026


    Pam Simon, MSN, CPNP, CPON
    Nurse Practitioner & Program Manager
    Stanford Adolescent and Young Adult Cancer Program (SAYAC)
    Palo Alto, CA
    H. Irene Su, MD MSCE
    Professor
    Reproductive Endocrinology and Infertility Fellowship Director
    Division of Reproductive Endocrinology and Infertility
    Co-Director, Center for Obstetrics and Gynecology Research Innovations
    Department of Obstetrics, Gynecology and Reproductive Sciences
    Director, Moores Cancer Center Leadership Academy
    University of California San Diego
    San Diego, CA
    In this episode, we’re joined by Dr. Irene Su, Professor of Obstetrics, Gynecology, and Reproductive Sciences at UC San Diego, and Pam Simon, Nurse Practitioner and Program Manager of the Stanford Adolescent and Young Adult (AYA) Cancer Program at Stanford Medicine. They discuss fertility risk across treatment types, approaches to fertility preservation and reproductive survivorship planning, insurance and access considerations, and the cultural and sociodemographic factors that shape care. They also share strategies to support shared decision-making and promote psychosocial well being for AYA patients and survivors. Tune in for practical insights to strengthen your approach to fertility care for AYAs.

    Mentioned on this episode:

    • OncofertilityRisk.com
    • The Alliance for Fertility Preservation

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Resources for Patients
    Show More Show Less
    38 mins
  • Building Resilience: Burnout & Compassion Fatigue Tools for HCPs

    Building Resilience: Burnout & Compassion Fatigue Tools for HCPs
    Jan 23 2026

    Chelsey Winegar, LCSW, MBA, Intermountain Health, Murray, UT

    Recorded on January 8, 2026


    Chelsey Winegar, LCSW, MBA
    Manager of Oncology Services
    Intermountain Health
    Murray, UT
    Join Chelsey Winegar, LCSW and Manager of Oncology Services at Intermountain Health in Murray, UT, as she breaks down the key differences between burnout and compassion fatigue, and why understanding both is essential for the well being of healthcare professionals and the patients they serve. Chelsey shares practical strategies for recognizing early warning signs, monitoring staff wellness, and building supportive, stigma free environments. The episode also highlights resources and education to help clinicians maintain resilience in demanding clinical settings. Listen in to learn more today!

    Mentioned on this episode:

    • Trauma Stewardship

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Resources for Patients
    Show More Show Less
    37 mins
  • Key Insights from Attending ASH 2025

    Key Insights from Attending ASH 2025
    Jan 13 2026

    Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC

    Recorded on December 18, 2025


    Lore Gruenbaum, PhD
    Chief Scientific Officer & Senior Vice President of Research
    Blood Cancer United
    Washington, DC
    Join Dr. Lore Gruenbaum, Chief Scientific Officer and Senior Vice President of Research at Blood Cancer United, to provide practice-changing data in hematologic malignancies from the 67th American Society of Hematology (ASH) Annual Meeting. Explored are breakthroughs in multiple myeloma, AML, CLL, and advances in cell therapy. Discussion also covers the growing use of artificial intelligence to accelerate precision medicine, spotlighting the Blood Cancer United Beat AML® Master Clinical Trial as a model for AI-driven trial design and real-time clinical decision-making. Tune in today for the key takeaways you need to know!

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Resources for Patients
    Show More Show Less
    34 mins
  • Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know

    Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know
    Dec 17 2025

    Raymond Mailhot, MD, MPH, University of Miami, Miami, FL

    Recorded on December 2, 2025


    Raymond Mailhot, MD, MPH
    Department of Radiation Oncology
    University of Miami
    Miami, FL
    Join us with Dr. Raymond Mailhot from the University of Miami as we explore how social determinants of health shape patient experiences, treatment decisions, and outcomes. He discusses the importance of cultural competence in delivering equitable, patient-centered care and shares practical communication strategies to better engage patients and collaborate effectively. This episode offers actionable insights to strengthen relationships and improve overall care quality. Tune in today to gain practical strategies that will enhance your approach to patient-centered care and drive better outcomes!

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Medical Debt Case Management Program for Patients
    • Blood Cancer United Additional Resources for Patients
    Show More Show Less
    31 mins
  • Hairy Cell Leukemia: Strategies for Improved Patient Outcomes

    Hairy Cell Leukemia: Strategies for Improved Patient Outcomes
    Nov 20 2025

    Paul J. Hampel, MD, Mayo Clinic, Rochester, MN

    Recorded on November 4, 2025


    Paul J. Hampel, MD
    Assistant Professor of Medicine
    Division of Hematology, Department of Medicine
    Mayo Clinic
    Rochester, MN
    In this episode, Dr. Paul Hampel from Mayo Clinic Rochester takes a comprehensive look at hairy cell leukemia (HCL). He reviews the current diagnostic work-up, including immunophenotypic and molecular testing, and highlights key clinical features that distinguish HCL from related disorders. Dr. Hampel also discusses approved frontline therapies and evidence-based approaches for relapsed or refractory disease, with attention to infection risk and supportive care. The conversation explores emerging agents, novel combinations, and clinical trials shaping the next wave of HCL management. Join us for this expert discussion, offering practical insights to enhance care and outcomes for patients with HCL.

    Show More Show Less
    40 mins
  • Managing CML: What HCPs Need to Know

    Managing CML: What HCPs Need to Know
    Nov 6 2025

    Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center, New York, NY

    Recorded on October 23, 2025


    Michael J. Mauro, MD
    Director, Chronic Myeloid Leukemia Program
    Professor of Medicine, Leukemia Service
    Memorial Sloan Kettering Cancer Center
    New York, NY
    Tune in for this expert-led discussion with Dr. Michael Mauro from Memorial Sloan Kettering Cancer Center on the evolving management of chronic myeloid leukemia (CML) in the era of tyrosine kinase inhibitors (TKIs) and newly approved FDA therapies. Dr. Mauro explores how TKIs have transformed prognosis, key factors guiding initial therapy selection, and best practices for managing treatment-related side effects. He also shares updates on TKI discontinuation criteria, long-term monitoring, and a forward look at ongoing trials and emerging therapeutic advances shaping the future of CML care. Gain actionable insights to enhance patient outcomes today!

    Show More Show Less
    37 mins
  • Understanding MRD: Insights for clinical practice and patient care

    Understanding MRD: Insights for clinical practice and patient care
    Oct 10 2025

    Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA

    Recorded on September 25, 2025


    Rahul Banerjee, MD, FACP
    Assistant Professor
    Fred Hutchinson Cancer Center
    Seattle, WA
    In this episode, Dr. Rahul Banerjee from Fred Hutchinson Cancer Center in Seattle, WA, discusses the evolving role of measurable residual disease (MRD) in hematologic malignancies. He explores what MRD is, how assays are used and interpreted, and its impact across the disease continuum. The conversation also covers MRD’s role in clinical trials, how to effectively explain MRD to patients, practical considerations for testing in community settings, and key education resources for both healthcare professionals and patients. Tune in today to gain practical insights you can apply in your daily practice!

    This episode is supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.
    Show More Show Less
    32 mins